Technical Analysis for ATXI - Avenue Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 2.63% | |
| NR7 | Range Contraction | 2.63% | |
| Narrow Range Bar | Range Contraction | 2.63% | |
| Inside Day | Range Contraction | 2.63% | |
| Wide Bands | Range Expansion | 2.63% | |
| Oversold Stochastic | Weakness | 2.63% | |
| Stochastic Buy Signal | Bullish | 1.04% | |
| Pocket Pivot | Bullish Swing Setup | 1.04% | |
| Wide Range Bar | Range Expansion | 1.04% | |
| Lower Bollinger Band Walk | Weakness | 1.04% |
| Alert | Time |
|---|---|
| Possible NR7 | 24 minutes ago |
| Rose Above Previous Day's High | about 5 hours ago |
| Up 3% | about 5 hours ago |
| Up 2% | about 5 hours ago |
| Up 1% | about 5 hours ago |
Get a Trading Assistant
- Earnings date: 11/11/2024
Avenue Therapeutics, Inc. Description
Avenue Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in acquiring, licensing, developing and commercializing products principally for use in the acute or intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol, an intravenous formulation of tramadol hydrochloride (HCl), for the management of moderate to moderately severe postoperative pain. Tramadol, a synthetic dual-acting opioid, is a centrally acting analgesic with weak opioid agonist properties. It also works via the inhibition of serotonin and noradrenaline re-uptake and blocking nociceptive impulses at the spinal level. Tramadol is also combined with acetaminophen (APAP) or nonsteroidal anti-inflammatory drugs (NSAIDS) in clinical practice. During the year ending December 31, 2016, the Company had completed a pharmacokinetics (PK) study for IV Tramadol in healthy volunteers.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Drugs Chemical Compounds Opioids Chloride Analgesics Amines Neurochemistry Hepatotoxins Pharmacokinetics Paracetamol Nonsteroidal Anti Inflammatory Drug
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 26.4675 |
| 52 Week Low | 1.6 |
| Average Volume | 49,483 |
| 200-Day Moving Average | 5.30 |
| 50-Day Moving Average | 2.28 |
| 20-Day Moving Average | 2.16 |
| 10-Day Moving Average | 2.06 |
| Average True Range | 0.21 |
| RSI (14) | 37.50 |
| ADX | 17.53 |
| +DI | 14.35 |
| -DI | 28.44 |
| Chandelier Exit (Long, 3 ATRs) | 2.06 |
| Chandelier Exit (Short, 3 ATRs) | 2.24 |
| Upper Bollinger Bands | 2.53 |
| Lower Bollinger Band | 1.80 |
| Percent B (%b) | 0.14 |
| BandWidth | 33.99 |
| MACD Line | -0.09 |
| MACD Signal Line | -0.06 |
| MACD Histogram | -0.0312 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.01 | ||||
| Resistance 3 (R3) | 2.01 | 1.99 | 1.99 | ||
| Resistance 2 (R2) | 1.99 | 1.96 | 1.98 | 1.98 | |
| Resistance 1 (R1) | 1.94 | 1.94 | 1.97 | 1.94 | 1.98 |
| Pivot Point | 1.92 | 1.92 | 1.93 | 1.91 | 1.92 |
| Support 1 (S1) | 1.87 | 1.89 | 1.90 | 1.87 | 1.82 |
| Support 2 (S2) | 1.85 | 1.87 | 1.84 | 1.82 | |
| Support 3 (S3) | 1.80 | 1.85 | 1.81 | ||
| Support 4 (S4) | 1.80 |
